Grifols, ES0171996087

Grifols stock trades at EUR 9.97 with 368,072 shares versus 577,735 average

Published on 10/09/2026 at 15:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Grifols stock stood at EUR 9.97 on October 9, 2026 versus EUR 9.83. The move was plus 1.42 percent versus the prior close.

Key points in brief

Grifols stock was trading at EUR 9.97 at Lang & Schwarz on October 9, 2026, up 1.42 percent from EUR 9.83.
Volume stood at 368,072 shares versus an average of 577,735 on October 8, 2026.
Grifols had a P/E ratio of 14.90 and market capitalization of USD 6.3 billion on October 8, 2026.
Makkler listed 9 Buy, 3 Hold and 1 Sell ratings with an average target of EUR 15.55.
MyPortfolio lists November 10, 2026, for Grifols third-quarter results.

Aquarellbild von Barcelona mit Hafen, Bergen und mediterranem Licht — Aquarellmalerei zeigt die Küstenstadt Barcelona als Sitz von Grifols S.A. ES0171996087 in weichen, warmen Farbtönen, Illustration mit AI erstellt.

At Lang & Schwarz, Grifols (ISIN ES0171996087) was trading at EUR 9.97 on October 9, 2026 at 3:13 p.m. CEST, up 1.42 percent from the EUR 9.83 prior close. The session price sits alongside 368,072 shares traded against an average volume of 577,735, both dated October 8, 2026.

Volume trails its average

The volume comparison puts the current move in perspective: reported activity was 209,663 shares below the average, a 36.29 percent difference. The euro quotation also remains below the 52-week high of USD 9.90 and above the 52-week low of USD 6.96, based on the October 8, 2026 market snapshot.

Valuation and analyst view

Grifols had a P/E ratio of 14.90 and a market capitalization of USD 6.3 billion on October 8, 2026. Those figures use the USD quotation, while the article's reference price is the separate euro quote from Lang & Schwarz.

Makkler listed 9 Buy, 3 Hold and 1 Sell ratings, with an average 12-month target of EUR 15.55. That target was 55.97 percent above the Lang & Schwarz price of EUR 9.97, using the target-price comparison formula.

Comparison with peers

Grifols: plus 1.42 percent, P/E 14.90, market capitalization USD 6.3 billion

Haemonetics (NYSE, USD): plus 17.46 percent, P/E 58.56, market capitalization USD 5.4 billion

ADMA Biologics (NASDAQ, USD): plus 1.87 percent, P/E 14.76, market capitalization USD 2.4 billion

November results set the next date

MyPortfolio lists November 10, 2026, for Grifols third-quarter results. The date gives the market a defined calendar point for the next company-specific update.

Euro price remains the anchor

Grifols stock was trading at EUR 9.97 at Lang & Schwarz on October 9, 2026 at 3:13 p.m. CEST, plus 1.42 percent versus the EUR 9.83 prior close. The further course of trading is shown by the continuously updated real-time quote of Grifols stock.